Adiponectin, which is secreted specifically by adipose tissue, has been shown to act as an antiatherosclerotic protein by direct effects on endothelial cells. Clinical studies have shown that adiponectin levels are lower in individuals with obesity, diabetes and coronary artery disease. The present study investigated relationships between serum adiponectin levels and body mass index (BMI), blood pressure, insulin resistance index, lipid profile, uric acid and high-sensitivity C-reactive protein levels in a large number of Japanese subjects not taking any medication for metabolic disease and without severe illness (705 men and 262 women ; age 30-65 years ; BMI 22.5p2.9 kg/m 2 ). The serum adiponectin concentration was measured by ELISA, without a protein-denaturing step. The insulin resistance index was assessed by homoeostasis model assessment (HOMA-IR). The serum concentration of adiponectin in women (13.5p7.9 µg/ml) was significantly higher than that in men (7.2p4.6 µg/ml). The serum adiponectin level was negatively correlated with BMI, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, insulin, HOMA-IR, total cholesterol, triacylglycerols, low-density lipoprotein (LDL)-cholesterol and uric acid, and positively correlated with high-density lipoprotein (HDL)-cholesterol. The correlations between serum adiponectin level and insulin, HOMA-IR, triacylglycerols, HDL-cholesterol, LDL-cholesterol and uric acid were significant even after adjustment for age, sex and BMI. Stepwise multiple regression analysis revealed that HDLcholesterol, sex, BMI and HOMA-IR were independently correlated with the serum adiponectin level (R 2 l 0.377). These findings suggest that the serum adiponectin level is negatively correlated with HOMA-IR and positively correlated with HDL-cholesterol, independent of age, sex and BMI, in the Japanese population.
INTRODUCTION
Obesity, which is characterized by the accumulation of excess adipose tissue, is a risk factor for diabetes mellitus, hypertension, hyperlipidaemia, and atherosclerotic diseases such as coronary artery disease, although it is unclear how these complications develop in obesity. Since the discovery of the obese (ob) gene and its product, leptin [1] , adipose tissue has been considered to be not only an energy storage organ, but also an endocrine organ that secretes various hormones.
Gelatin-binding protein of 28 kDa (GBP28) was obtained from human plasma by means of its affinity for gelatin-Cellulofine [2] . In addition, an adipose-specific gene, apM1, the transcript of which is the most abundant in the mRNA population of human adipose tissue, has been isolated [3] . Its gene product, adiponectin [4] , is identical to GBP28. The plasma concentration of adiponectin, quantified by an ELISA system, was paradoxically lower in obese subjects than in non-obese subjects [4] , despite the fact that adiponectin is secreted only by adipose tissue. It was reported that adiponectin inhibited tumour necrosis factor α-induced expression of endothelial adhesion molecules [5] by inhibition of nuclear factor-κB signalling pathways [6] . Immunohistochemical analysis revealed adiponectin in the walls of catheterinjured vessels, but not in intact vascular walls [7] . Thus it has been demonstrated that adiponectin acts as antiatherosclerotic factor by direct effects on endothelial cells. Recently, Yamauchi et al. [8] and Berg et al. [9] reported that adiponectin (also named Acrp30 [10] ) reverses insulin resistance in various mouse models of obesity and diabetes.
In clinical studies, Hotta et al. [11] reported that the plasma adiponectin concentration was related to the body mass index (BMI), the serum triacylglycerol level and the presence of diabetes or coronary artery disease in 183 patients with Type II diabetes and 82 healthy subjects. Weyer et al. [12] reported that the plasma adiponectin concentration was positively correlated with insulin sensitivity, measured by the hyperinsulinaemic euglycaemic clamp method. In addition, the degree of hypoadiponectinaemia was more closely related to the degree of insulin resistance and hyperinsulinaemia than to the degree of adiposity or glucose intolerance in 23 Caucasians and in 121 Pima Indians, a population with strong propensity for obesity and Type II diabetes [13, 14] .
However, there are few studies in a large number of non-diabetic subjects concerning adiponectin levels and insulin resistance. In the present study, we measured the serum adiponectin concentration in 967 Japanese subjects not taking medication for any metabolic disease, using an ELISA without a protein-denaturing step, and investigated its relationships with BMI, blood pressure, insulin resistance index, lipid profile, etc.
METHODS

Subjects
The study group comprised 705 male and 262 female teachers and workers in Keio University, aged 30-65 years, who received an annual health check-up. Subjects with endocrine disease, significant renal or hepatic disease, coronary artery disease or cerebral vascular disease, and those receiving medication for diabetes mellitus, hypertension or hyperlipidaemia, were excluded from the analyses.
The present study was conducted according to the principles expressed in the Declaration of Helsinki. Informed consent was obtained from each subject after full explanation of the purpose, nature and risk of all procedures used. The protocol was approved by the ethical review committee of the Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Measurements
Systolic blood pressure and diastolic blood pressure were measured twice with the subject in the sitting position after resting for at least 5 min. Height, weight, fasting plasma glucose, serum insulin, adiponectin, total cholesterol, triacylglycerol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol and uric acid levels were measured in the morning after an overnight fast. Plasma glucose, lipids and uric acid were assayed by routine automated laboratory methods, as described previously [15] [16] [17] [18] . The serum insulin concentration was measured by an enzyme immunoassay, using a commercially available kit (Tosoh, Tokyo, Japan). The insulin resistance index was assessed by homoeostasis model assessment (HOMA-IR) [19, 20] . Highsensitivity C-reactive protein (hsCRP) in serum was measured using a latex-enhanced immunonephelometric assay on a BN II analyser (BNA ; Dade Behring) ; this parameter was measured only in female subjects.
Measurement of adiponectin by ELISA
Serum was diluted 441-fold before assay. Then 100 µl of diluted sera, standard samples of adiponectin (GBP28) and quality-control samples were applied to 96-well microtitre plates coated with mouse anti-(human GBP28) monoclonal antibody. This antibody recognizes only the native GBP28 oligomer [2] . After incubation at room temperature for 60 min, the wells were washed and incubated for 30 min with the same monoclonal antibody labelled with horseradish peroxidase. The wells were washed again and incubated for 30 min with tetramethylbenzidine reagent. Then 100 µl of 0.18 M H # SO % was added to each well to stop the reaction, and the absorbance at 450 nm was measured. The dilution curve was parallel to the standard curve. Intra-and inter-assay coefficients of variance were 4.8-4.9 % and 3.3-6.8 % respectively.
Statistical analysis
All statistical analyses were performed using the StatView2 program for Windows (version 5.0-J ; SAS Institute Inc., Cary, NC, U.S.A.). Relationships between adiponectin levels and other parameters were analysed by simple correlation and by multiple and stepwise linear regressions. Stepwise regression was performed in a forward direction with F for the entry set to 4. Because serum insulin, hsCRP, triacylglycerol, adiponectin levels and HOMA-IR were normally distributed after logarithmic transformation, the logarithms of these parameters were used for the analyses. All data are expressed as meanspS.D., and values of P 0.05 were considered statistically significant.
RESULTS
Serum adiponectin concentration
The intact oligomer of adiponectin was abundantly present in serum, its level ranging from 0.4 to 62.6 µg\ml. The serum concentration of adiponectin in women (13.5p7.9 µg\ml) was significantly higher (P 0.0001) than that in men (7.2p4.6 µg\ml). We excluded from the analysis six male subjects who had suffered from coronary artery disease or cerebral infarction. Their adiponectin level in serum was 4.8p2.1 µg\ml, which was much lower than for the other subjects.
Relationships between serum adiponectin level and clinical and metabolic parameters in Japanese men and women
As shown in Table 1 , the serum adiponectin level was negatively correlated with BMI, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, insulin, HOMA-IR, total cholesterol, triacylglycerols, LDLcholesterol and uric acid, and positively correlated with HDL-cholesterol. The correlations between serum adiponectin level and insulin, HOMA-IR, triacylglycerols, HDL-cholesterol, LDL-cholesterol and uric acid were significant even after adjustment for age, sex and BMI. Although fasting plasma glucose tended to be negatively correlated with the serum adiponectin level after adjustment for age, sex and BMI, this did not reach statistical significance (P l 0.086). Stepwise multiple regression analysis revealed that HDL-cholesterol, sex, BMI and HOMA-IR were independently correlated with the serum adiponectin level (Table 2 ) (R# l 0.377).
Because gender was an independent predictor of serum adiponectin level, we further analysed the relationships between serum adiponectin level and clinical and metabolic parameters in men and women separately.
Relationships between serum adiponectin level and clinical and metabolic parameters in Japanese men
As shown in Table 3 , the serum adiponectin level was negatively correlated with BMI, systolic blood pressure, diastolic blood pressure, fasting plasma glucose, insulin, HOMA-IR, triacylglycerols, LDL-cholesterol and uric acid, and positively correlated with HDL-cholesterol, in men. The correlations between serum adiponectin level and insulin, HOMA-IR, triacylglycerols, HDL-cholesterol, LDL-cholesterol and uric acid were significant even after adjustment for age and BMI. Stepwise multiple regression analysis revealed that HDL-cholesterol, BMI and HOMA-IR were independently correlated with the serum adiponectin level in men (Table 4 ) (R# l 0.229).
Relationships between serum adiponectin level and clinical and metabolic parameters in Japanese women
As shown in Table 5 , the serum adiponectin level was negatively correlated with BMI, insulin, HOMA-IR, triacylglycerols, LDL-cholesterol and hsCRP, and positively correlated with HDL-cholesterol, in women. The correlations between serum adiponectin level and insulin, HOMA-IR, triacylglycerols, HDL-cholesterol and LDL-cholesterol were significant even after adjustment for age and BMI. Stepwise multiple regression analysis revealed that HDL-cholesterol and HOMA-IR were independently correlated with the serum adiponectin level in women (Table 6 ) (R# l 0.184).
DISCUSSION
Adiponectin is a plasma protein that is secreted specifically by adipocytes, and its function as an antiatherosclerotic factor is being clarified [5] [6] [7] . In the present study, we demonstrate relationships between adiponectin and insulin resistance index, lipids and blood pressure, which are important risk factors for the development of atherosclerosis. The serum adiponectin level was negatively correlated with HOMA-IR in both men and women, even after adjustment for age and BMI. As for lipid profiles, individuals with a higher adiponectin level had lower LDL-cholesterol, lower triacylglycerol and higher HDL-cholesterol. Because both adiponectin and lipids were correlated with BMI, we adjusted for age and BMI, but the correlations between lipids and adiponectin were still significant. The results of this study indicate that adiponectin is related to insulin resistance index and lipid profile, independent of age and BMI, whereas the effects of adiponectin on blood pressure and hsCRP (in women) are thought to be indirect, because the correlations with these parameters were not significant after adjustment for age and BMI.
The present study shows that, when the adiponectin level is high, insulin resistance is low and the lipid profile is good. It is unclear, however, whether adiponectin improves both insulin resistance and lipid profile, or whether low insulin resistance and\or a good lipid profile increase the plasma adiponectin level. Animal studies have revealed that acute treatment of mice with the globular head domain of Acrp30, the mouse counterpart of adiponectin, significantly decreased plasma glucose, non-esterified fatty acid and triacylglycerol levels through an acute increase in fatty acid oxidation by muscle [21] . In a study of Pima Indians, Weyer et al. [12] reported that the plasma adiponectin level was positively correlated with insulin sensitivity. However, they did not check the relationship between adiponectin and lipids. We [22] and others [23] have shown recently that administration of thiazolidinediones increases plasma adiponectin levels in diabetic subjects.
Furthermore, a genome scan in French Caucasians provided strong evidence for a susceptibility locus for diabetes and impaired glucose tolerance on chromosome 3q27 [24] , where the adiponectin gene (apM1) is located. Also, pedigree-based analysis using a variance components linkage model demonstrated a quantitative trait locus on chromosome 3q27 that is strongly linked to the metabolic syndrome [25] . When these and more recent reports [8, 9] are taken into consideration, the possibility that adiponectin improves insulin resistance and lipid profile seems more likely.
Adiponectin is an adipocyte-derived protein, which is abundant in the bloodstream. The plasma adiponectin concentration is low in patients with coronary artery disease [11] , and a relationship between hypoadiponectinaemia and atherosclerosis is suggested. The present study shows that the serum adiponectin level was negatively correlated with HOMA-IR and positively correlated with HDL-cholesterol, independent of age, sex and BMI, in a Japanese population. It is suggested that adiponectin may act as an anti-atherosclerotic factor not only through direct effects on endothelial cells, but also through improving insulin resistance and lipid profile.
